维普期刊资源整合服务平台（V6.5）

290篇 您的检索式：作者名="MIRAVITLLES M"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients:a multiple logistic regression analysis显示文摘	Miravitlles M Guerrero T Mayordomoc	2000	Resiration2000，67，5：	2
2	Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chron- ic obstructive pulmonary disease 显示文摘	Welte T Miravitlles M Hernandez P	2009	Am J Respir Crit Care Med2009，180，：	1
3	Exacerbations of chronic obstructive pulmonary disease:when are bacteria important?显示文摘	Miravitlles M	2002	Eur Respir J Suppl2002，36，：	1
4	Clinical phenotypes of COPD:identifieation, definition and implications for guide lines 显示文摘	Miravitlles M Calle M Soler-Catalufia JJ	2012	Arch Bronconeumologta ( English Edition)2012，48，3：	1
5	Moxifloxacin in respiratory tract infections显示文摘		2005	Expert Opin Pharmacother2005，6，2：	1
6	Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD:MAESTRAL results显示文摘	Wilson R Anzueto A Miravitlles M	2012	Eur Respir J2012，40，1：	1
7	The asthmachronic obstructive pulmonary disease overlap syndrome(ACOS):opportunities and challenges显示文摘	Barrecheguren M Esquinas C Miravitlles M	2015	Cur Opin Pulm Med2015，21，1：	1
8	Chronic obstructive pulmonary disease显示文摘	Decramer M Janssens W Miravitlles M	2012	Lancet2012，379，9823：	1
9	Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD 显示文摘	BRUSASCO V HODDER R MIRAVITLLES M	2003	Thorax2003，58，：	1
10	Chronic ob-structive pulmonary disease 显示文摘	DECRAMER M JANSSENS W MIRAVITLLES M	2012	Lancet2012，379，9823：	1
11	Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities 显示文摘	Miravitlles M Soriano JB Garcia-Rio F	2009	Thorax2009，64，10：	1
12	Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD显示文摘	Brusasco V Hodder R Miravitlles M	2003	Thorax2003，58，5：	1
13	Treatment with the im- munomodulator Am3 improves the health-related quality of life of patents with COPD 显示文摘	Alvarez M Miravitlles M Morera J	2005	Chest2005，127，：	1
14	Costs of chronic bronchitis and COPD: A 1-year follow-up study显示文摘	Miravitlles M Murio C Guerrero T	2003	Chest2003，123，3：	1
15	Course of COPD assessment test(CAT) and clinical COPD questionnaire(CCQ) scores during recovery from exacerbations of chronic obstructive pulmo- nary disease显示文摘	Miravitlles M Garc~a-Sidro P Fem6ndez-Nistal A	2013	Health Qual Life Outcomes2013，11，1：	1
16	Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? 显示文摘	Miravitlles M	2002	Ettr Respir J2002，，：	1
17	Chronic obstruc- tive pulmonar;/disease 显示文摘	Decramer M Janssens W Miravitlles M	2012	Lancet2012，379，9823：	1
18	Moxifloxacin: a respiratory fluoroquinolo- ne显示文摘	Miravitlles M Anzueto A	2008	Expert Opin Pharmacother2008，9，10：	1
19	Systemic inflamma- tion in chronic obstructive pulmonary disease: a populationbased study 显示文摘	Garcia - Rio F Miravitlles M Soriano JB	2010	RespirRes2010，11，1：	1
20	Antibiotic prophylaxis in COPD:Why,when,and for whom显示文摘	Miravitlles M Anzueto A	2014	Pulm Pharmacol Ther2014，，14：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示